ABSTRACT: We have previously constructed recombinants encoding the full-length and truncated forms of cystatin-SN and expressed these in the Escherichia coli expression system pGEX-2T, which expresses foreign sequences as fusion proteins with glutathione S-transferase (GST). Recombinant cystatins were produced and purified in large quantities. The full-length recombinant cystatin-SN exhibited comparable biological activity and secondary structure to natural cystatin, validating the use of the full-length and mutant recombinant proteins for structure-function studies of salivary molecules. In this study, we have expressed histatin-1 cDNA in the pGEX-3X vector and cystatin-SN/histatin-l or cystatin-SN/histatin-3 chimeric cDNAs in the pGEX-2T vector. Gene splicing by overlap extension (SOE), a PCR-based method, was used for generating the chimeric cDNAs. Each construct was analyzed by DNA sequencing, which showed the correct junctions and reading frames between the GST/histatin-l and the GST/cystatin/histatin cDNAs. Expression of histatin and cystatin/histatin chimeras was induced by IPTG and the production of the fusion proteins monitored by SDS-PAGE/Coomassie blue staining and in the case of the GST/cystatinfhistatin fusion proteins, also by Western blot using anti-cystatin antibody. The results of these studies showed that we have successfully constructed recombinants encoding the individual and chimeric salivary molecules and efficiently expressed these in E. coli expression system pGEX. Purification and characterization of recombinant histatin and cystatin-histatin hybrid proteins are presently ongoing.
INTRODUCTION
Salivary molecules have many protective functions critical for oral health (Mandel, 1987) . Some exert antimicrobial activities and are therefore important components of the host non-immune defense system. The protective qualities of saliva are evident in individuals with markedly decreased salivary flow, termed xerostomia or dry mouth. Symptoms associated with xerostomia include an increase in oral microbial infections such as gingivitis and candidiasis (Aneksuk, 1989; Greenspan, 1990; Fox, this conference) .
The cystatin superfamily of proteins derived from a common ancestor (for review, see Rawlings and Barrett, 1990 ) is composed of a diverse group of potent cysteine proteinase inhibitors (Abrahamson etal., 1986; Barrett et al., 1986 ) and anti-bacterial/viral agents (Korant, et al., 1988; Bjorck et al., 1989 Bjorck et al., , 1990 . Cystatins have been isolated from many different human and animal tissues and body fluids (Turk et al., 1985) . Human salivary cystatins were isolated from human submandibular-sublingual saliva by Shomers etal. (1982a,b) and Ramasubbu and co-workers (1991) . Isemura et al. (1984 Isemura et al. ( , 1986 Isemura et al. ( , 1987 isolated and determined the amino acid sequence of salivary cystatin-S, cystatin-SN (neutral pl), and cystatin-SA (acidic pl) from human whole saliva. At that time these comprised 113 residues; however, the full-length salivary cystatins comprise 121 residues. Salivary cystatins inhibit cysteine proteinases in vitro, are involved in the formation of the in vivo acquired enamel pellicle (Levine et al., 1985; Al-Hashimi and Levine, 1989) , and may play a role in mineralization processes (Shomers et al., 1982a; Johnsson et al., 1991) . Although much attention has been paid to physiological functions and inhibitory mechanisms of cystatins, the precise structural requirements for these activities remain to be determined.
Histatins comprise a family of related histidinerich polypeptides (Oppenheim et al., 1988) . The bactericidal effect of histatins on Streptococcus mutans was found by MacKay et al. (1984) and their inhibitory activity on growth of Candida albicans was shown by Pollock et al. (1984) and Oppenheim et al. (1988) . In addition, Murakami etal. (1991) reported that histatin binds to Porphyromonas gingivalis and strongly inhibits its hemagglutinating activity. Three major mem-bers, histatins 1, 3, and 5 (38, 32, and 24 amino acid residues, respectively), were isolated and sequenced and their candidacidal activity appeared to be inversely proportional to chain length (Oppenheim et al., 1988) . More recently, Raj et al. (1989) demonstrated that the C-terminal of histatin 5 with a minimum chain length of 14 residues and a-helical conformation were important for appreciable candidacidal activity.
The long-range goal of our research is to design and produce individual and/or chimeric human salivary molecules with enhanced protective functions (e.g., anticandidal, antibacterial, antiviral, increased substantivity). Future directions toward the development of an artificial saliva with enhanced functions are described by Levine et al. (1987, this conference) . In this study, we are using molecular biological techniques to elucidate the structural basis for the protective functions of salivary cystatins and histatins. These are among the best characterized on a biochemical basis, have known protective functions, and are naturally occurring antimicrobial agents; thus, they lack any degree of toxicity to mammalian cells. Previously, we isolated recombinant clones encoding salivary cystatin-SN and cystatin-S and expressed the full-length cystatin cDNAs in Escherichia coli expression systems and analyzed the recombinant proteins (Al- Hashimi et al., 1988; Bobek et al., 1990 Bobek et al., , 1991a Bobek et al., ,b, 1992 Bobek et al., , and 1993 . The comparable biological activity and secondary structure of the full-length recombinant and natural cystatin validated the use of the recombinant proteins for the structure-function studies. In this article, we describe in detail the construction of plasmids with histatin and cystatin/histatin chimeric cDNAs and their expression in E. coli. Because mutants provide one of the most powerful ways to study the structure-function relationships of any protein, characterization of the functional domains will be accomplished by construction of mutants and other chimeric (hybrid) forms, followed by expression, purification, and functional analysis of produced proteins. This research aims to generate information that will permit a general approach for the design of salivary substitutes with enhanced protective properties.
II. EXPERIMENTAL PROCEDURES AND RESULTS
A. Selection and Analysis of cDNA Clones Encoding Salivary Cystatins and Histatins
The human submandibular gland (HSMG) cDNA expression library (in Xgtl 1 Sfi-Not vector) was constructed and the clones encoding cystatin-SN and -S identified as previously described (Bobek et al., 1991a,b) . The composite nucleotide sequences and the decoded amino acid sequences of these clones were previously published (Bobek et al., 1991b) .
Clones encoding histatin-1 were selected with a mixed synthetic oligonucleotide probe based on the sequence of the amino acids 23 to 28, which are unique to histatin-1 (Oppenheim et al., 1988) . The oligonucleotide was a mixed 17-mer of the following sequence: 5'-CCA(G)TAG(A)AAA(GTC)GGG(A)AAT(C)TC-3'. Several positive clones were subcloned into pGem 1 lZf+ vector and sequenced by dideoxynucleotide chain termination sequencing method (Sanger et al., 1977) . The sequence of one of these clones, designated H6-1, is shown in Figure 1 . The sequence of H6-1 agrees with the one determined by Sabatini and Azen (1989) , but it is longer at the 5'-end by 47 nucleotides. It differs from that determined by VanderSpek et al. (1990) in the region of the leader peptide sequence encoding amino acid residues 11, 12, and 13 (Ala, Leu, Met, respectively, in the present study vs. Val, Met, Leu in the VanderSpek study) and is longer at both the 5' and 3' ends. A cDNA clone encoding histatin-3 was isolated by rescreening the HSMG cDNA expression library with the insert of the cDNA clone H6-1. Direct DNA sequencing of the PCR amplified inserts, performed as previously described for cystatin-S (Bobek et al., 199 lb) , showed that one encoded a full-length secreted histatin-3, including a leader peptide and the 5' and 3-untranslated regions (not shown). Its sequence agreed with those published previously (Dickinson et al., 1987; Sabatini and Azen, 1989; VanderSpek et al., 1990 ).
B. Expression of Histatin-1 in E. coil
The pGEX Plasmid Expression Vectors
The pGEX-1, pGEX-2T, and pGEX-3X direct the synthesis of foreign polypeptides in E. coli as fusion proteins with the C-terminus of a 26-kDa glutathione S-transferase (GST) encoded by the parasitic helminth Schistosomajaponicum (Smith and Johnson, 1988; see Figure 2 ). In addition, the pGEX-2T and pGEX-3X have been engineered so that the GST carrier protein can be cleaved from cloned proteins by the site-specific protease thrombin and coagulation factor X, respectively. the histatin-1 cDNA clone were used. To keep the histatin cDNA fragment in a correct reading frame, cohesive ends of the Hinfl-EcoRI fragment ( Figure 1 ) encoding a full-length secreted polypeptide were filled in and the fragment was ligated into a EcoRI-digested and blunt-ended pGEX-3X. This construct, therefore, expresses histatin-l with an additional five amino acid residues at the N-terminus (Gly, Ile, Pro, Gly, Asn) derived from the polylinker of the pGEX-3X ( Figure  2 ) and fused to the GST. Ligated DNAs were transformed into JM83 and transformants plated on LB/ ampicillin plates. Histatin recombinants were identified by colony hybridization using a histatin-l cDNA insert as a probe. DNA sequence analysis of inserts of several positive clones showed two transformants with the correct junctions and in-frame orientation between the GST and histatin-1.
Construction and Analysis of Transformants

Expression of GST/Histatin-1 Fusion Protein
Single colonies of the JM83 cells transformed with the pGEX-3X or pGEX-3X containing the histatin-1 insert were grown in LB/ampicillin media at 37°C to an absorbance of 0.8 at 660 nm. IPTG was then added (to 0.1 mM) and cultures allowed to grow for 3 to 5 h. Cells were harvested and protein production of the induced and uninduced cultures analyzed by SDS-PAGE. The results showed that the induced cells, transformed with the vector containing the histatin-l insert, produced a protein of higher molecular weight (apparently corresponding to the GST/histatin-I fusion protein) than the induced cells transformed with the vector only (expressing GST). Even though the level of GST/ histatin expression was high, the histatin portion of the fusion protein was often degraded after the cells were lysed during attempts to purify the protein (not shown). To make the fusion protein more stable, the recombinant plasmid was retransformed into AR68, a protease-deficient E. coli host. This resulted in the production of an intact GST/histatin-1 after the cell lysis (Figure 3, lanes 6-9) , and the level of expression was comparable with that obtained in the JM83 host. The GST/histatin-l was located mostly in the soluble (supematant) fraction (lane 8) in contrast to GST/cystatin that was located in the insoluble fraction. Thus, the GST/histatin can be purified directly from the superna- . Fragments that are to be recombined are generated in separate PCR reactions. In addition to being an improved method for recombining DNA, SOE can be used for the purpose of site-directed mutagenesis or a site-directed mutagenesis simultaneously with recombination . The primers are designed so that the ends of the PCR products contain complementary sequences, making the PCR products of the first reactions overlap at the ends to be joined. These are mixed, denatured and reannealed, and primer-extended to form a full-length recombinant product (sequences are spliced together) and then amplified by another PCR reaction. Schematic representations of cystatin-SN/ histatin-1 and cystatin-SN/histatin-3 chimera constructions are shown in Figure 4 .
Templates and Primers for PCR Reactions
The pGEX-2T expressing the full-length cystatin-SN, the pGEX-3X expressing histatin-1, and the kgtl 1 with histatin-3 cDNA insert were used as templates for generating the desired fragments. The scheme of templates and primers is depicted in Figure 4A. There is a unique BamHI recognition site located outside of the cystatin (part of the pGEX vector) and a unique EcoRI site located in the insert of histatin-1 (past the protein coding sequence). A unique EcoRI site was also incorporated into a primer for histatin-3 amplification (his-primer #4). These sites are important for cleavage of a final PCR chimeric product to facilitate subcloning into the pGEX-2T expression vector. The pGEX primer #1 (sense strand) and pGEX primer #4 (antisense strand) are located in the vector, about 50 bp on the outside of the pGEX cloning sites. C-H (cystatin-histatin) primer #2 (antisense) matches the cystatin gene in the 3'-portion (encoding the last four residues of the C-terminal end of cystatin-SN) and its 5'-portion matches the histatin gene (encoding the first three residues of the N-terminal of histatin-I or -3). C-H (cystatin-histatin) primer #3 (sense strand) is completely complementary to C-H primer #2. 3. Amplification of cDNA Fragments PCR reactions were carried out in automatic thermal cycles (COY, Ann Arbor, MI) for 30 cycles (each consisting of denaturation temperature of 94°C for I min, an annealing temperature [as indicated later this paragraph] for 2 min, and an extension temperature of 72°C for 2 min), followed by a 10-min incubation at 72°C to elongate the products to their full length. About 100 ng of templates and 100 pmol of each primer were used. The remaining conditions were as previously described (Bobek et al., 1991b) . Amplification of cystatin-SN (445 bp) was done with pGEX primer #1 and C-H primer #2 and amplification of histatin-3 in kgtl 1 (108 bp) with C-H primer #3 and his-primer #4 ( Figure 4A ) at annealing temperatures of 52°C. Amplification of histatin-1 (330 bp) in pGEX-3X was done with C-H primer #3 and pGEX primer #4 with an annealing temperature of 40"C. Amplified products were analyzed on agarose gels and the correct fragments recovered and purified using a Geneclean kit (Biol10, La Jolla, CA).
Splicing of Amplified Fragments by SOE
Splicing of cystatin-SN and histatin-1 (775 bp) is shown in Figure 4B . Purified amplified products from the first PCR reactions were melted and an- nealed at 52°C and then amplified in the second PCR reaction, using the pGEX primers #1 and #4. Similarly, splicing of cystatin-SN and histatin-3 (553 bp) was accomplished by melting the first PCR products, annealing at 52°C, and then amplifying in the second PCR reaction, using the pGEX primer #1 and the hisprimer #4. Final PCR products were analyzed on agarose gels and the correct fragments were recovered and purified. picked randomly, were grown in 3 ml of LB-ampicillin medium up to an absorbance of 0.8 at 660 nm. Expression was then induced by addition of IPTG (to 0.1 mM) and cultures were grown for 3 to 5 h. Cells were harvested and total extracts analyzed by SDS-PAGE/ Western blot using rabbit anti-human salivary cystatin antibody. Several clones showed expression of a protein apparently corresponding to GST/cystatin-SN/ histatin-1 or GST/cystatin-SNlhistatin-3 fusion proteins that also reacted with anti-cystatin antibody. The expression pattern of one of these clones is shown in Figure 5A ,B (lanes 9-1 1). figure. The results also showed that both the GST/cystatin-SN/histatin-l or -3 fusion proteins were located solely in the insoluble fractions (lane 11 for histatin-3 fusion protein), as was also the case for the GST/cystatin. These proteins, therefore, will be solubilized under denaturation conditions and then purifled by conventional means. As mentioned earlier, we have previously purified large amounts of biologically active recombinant human salivary cystatin from an E. coli insoluble fraction (Bobek et al., 1993) .
Confirmation of the Recombinant Plasmids by DNA Sequencing
The chimeric constructions were analyzed by the dideoxynucleotide termination method of DNA sequencing (Sanger et al., 1977 
DISCUSSION
A complete understanding of the function(s) of human salivary proteins requires a detailed structural knowledge of these molecules. The use of molecular biological techniques and recombinant DNA technology allows the study of the structure-function relationships of salivary molecules at the molecular level. Recombinant proteins with different structural variahistatin-3) salivary molecules and efficiently expressed these in E. coli. The comparable biological activity and secondary structure of the full-length recombinant and natural cystatins validated the use of the recombinant proteins for mapping the structural domains and/ or individual amino acids necessary for the biological function. Purification and characterization of recombinant histatin and cystatin-histatin hybrid proteins are presently ongoing. The information obtained from these studies can be used for construction and production of other chimeras with multiple functional domains that will retain or exceed the biological activities of parent proteins. In view of contribution of salivary molecules to nonimmune defense functions ofhuman saliva, such studies will provide the basis for the design and development of bioactive salivary substitutes.
